首页> 美国卫生研究院文献>Molecular Biology International >Soluble Expression and Characterization of Biologically Active Bacillus anthracis Protective Antigen in Escherichia coli
【2h】

Soluble Expression and Characterization of Biologically Active Bacillus anthracis Protective Antigen in Escherichia coli

机译:生物活性炭疽杆菌保护性抗原在大肠杆菌中的可溶性表达和鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bacillus anthracis secretory protein protective antigen (PA) is primary candidate for subunit vaccine against anthrax. Attempts to obtain large quantity of PA from Escherichia coli expression system often result in the formation of insoluble inclusion bodies. Therefore, it is always better to produce recombinant proteins in a soluble form. In the present study, we have obtained biologically active recombinant PA in small scale E. coli shake culture system using three different expression constructs. The PA gene was cloned in expression vectors bearing trc, T5, and T7 promoters and transformed into their respective E. coli hosts. The growth conditions were optimized to obtain maximum expression of PA in soluble form. The expression construct PA-pET32c in DE3-pLysS E. coli host resulted in a maximum production of soluble PA (15 mg L−1) compared to other combinations. Purified PA was subjected to trypsin digestion and binding assay with lethal factor to confirm the protein's functionality. Biological activity was confirmed by cytotoxicity assay on J774.1 cells. Balb/c mice were immunized with PA and the immunogenicity was tested by ELISA and toxin neutralization assay. This study highlights the expression of soluble and biologically active recombinant PA in larger quantity using simpler E. coli production platform.
机译:炭疽芽孢杆菌分泌蛋白保护性抗原(PA)是抗炭疽亚单位疫苗的主要候选药物。尝试从大肠杆菌表达系统获得大量的PA经常导致不溶性包涵体的形成。因此,总是最好以可溶形式生产重组蛋白。在本研究中,我们使用三种不同的表达构建体在小规模的大肠杆菌摇动培养系统中获得了具有生物活性的重组PA。将PA基因克隆到带有trc,T5和T7启动子的表达载体中,并转化到它们各自的大肠杆菌宿主中。优化生长条件以获得可溶形式的PA的最大表达。与其他组合相比,DE3-pLysS大肠杆菌宿主中的表达构建体PA-pET32c导致可溶性PA的最大产量(15μmgL -1 )。对纯化的PA进行胰蛋白酶消化和致命因子结合试验,以确认蛋白的功能。通过对J774.1细胞的细胞毒性测定证实了生物学活性。用PA免疫Balb / c小鼠,并通过ELISA和毒素中和试验测试免疫原性。这项研究强调了使用更简单的大肠杆菌生产平台可大量表达可溶性和生物活性重组PA的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号